Examining stage IIB survival in a population‐based cohort of patients with colorectal cancer
BACKGROUND: In Nova Scotia, Canada, a previous study of colorectal cancer (CRC) cases diagnosed between January 1, 2001, and December 31, 2005, found that patients with stage IIB CRC had similar 5‐year overall survival (OS) to those with stage IIIC cancer. This study sought to examine factors contri...
Gespeichert in:
| Veröffentlicht in: | Cancer 2012-12, Vol.118 (23), p.5973-5981 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5981 |
|---|---|
| container_issue | 23 |
| container_start_page | 5973 |
| container_title | Cancer |
| container_volume | 118 |
| creator | Urquhart, Robin Bu, Jingyu Grunfeld, Eva Dewar, Ron MacIntyre, Maureen Porter, Geoffrey A. |
| description | BACKGROUND:
In Nova Scotia, Canada, a previous study of colorectal cancer (CRC) cases diagnosed between January 1, 2001, and December 31, 2005, found that patients with stage IIB CRC had similar 5‐year overall survival (OS) to those with stage IIIC cancer. This study sought to examine factors contributing to the observed stage IIB outcome, specifically nodal harvest, receipt of chemotherapy, and use of a new coding system to derive stage.
METHODS:
The provincial cancer registry identified all CRC cases diagnosed during the study period and staged this cohort using the Collaborative Stage (CS) Data Collection System. All patients with stage II and III cancer in the cohort were examined. Kaplan‐Meier (KM) survival curves compared 5‐year OS for patients with stage IIB cancer based on the factors of interest, and compared patients with stage IIB cancer to those with stage IIA and III cancer.
RESULTS:
OS for patients with stage IIB cancer (n = 187) was 44.7%, and differed depending on adequacy of nodal harvest (P = .005) and whether pathological or clinical/mixed evidence was used to derive stage (P = .013). Pathologically‐staged patients with stage IIB cancer who had adequate nodal harvest had marginally improved OS compared to pathologically‐staged patients who had inadequate nodal harvest (P = .07), and improved survival compared to patients with clinical/mixed stage (P = .004). Pathologically‐staged patients with stage IIB cancer with adequate nodal harvest demonstrated similar 5‐year OS to those with stage IIA and III cancer (P = .52 and P = .25, respectively). Cox proportional hazards models supported these findings.
CONCLUSIONS:
The inclusion of clinical/mixed evidence into staging classification and, perhaps to a lesser extent, the adequacy of nodal harvest appear to contribute to the observed worse survival for patients with stage IIB versus stage III cancer. Cancer 2012. © 2012 American Cancer Society.
The inclusion of clinical and mixed evidence into the stage classification algorithms used by the Collaborative Stage Data Collection System and the adequacy of nodal harvest appear to have contributed to the poor survival that was observed in a population‐based cohort of patients with stage IIB colorectal cancer. The impact of nodal harvest on survival was less when stage was derived using only pathologic evidence. |
| doi_str_mv | 10.1002/cncr.27610 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1179514618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1179514618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3870-79096f0786c1d1925fba758685a8a998ce4c409cd53d8b013ff57230bf3008dd3</originalsourceid><addsrcrecordid>eNp90MlKBDEQBuAgio7LxQeQXAQRWiu9ZDnq4DIgCqLgySadTjTS02mTbpebj-Az-iRGZ9Sbp5DUlyrqR2iTwB4BSPdVq_xeyiiBBTQiIFgCJE8X0QgAeFLk2c0KWg3hIV5ZWmTLaCVNac4ZFyN0e_Qip7a17R0OvbzTeDI5xGHwT_ZJNti2WOLOdUMje-vaj7f3SgZdY-Xune-xM7iLBd32AT_b_j6-N85r1cevSrZK-3W0ZGQT9Mb8XEPXx0dX49Pk7OJkMj44S1TGGSRMgKAGGKeK1ESkhakkKzjlheRSCK50rnIQqi6ymldAMmMKlmZQmSyuWNfZGtqZ9e28exx06MupDUo3jWy1G0JJCBMFySnhke7OqPIuBK9N2Xk7lf61JFB-5Vl-5Vl-5xnx1rzvUE11_Ut_Aoxgew5kULIxPq5tw5-jlAkKLDoyc8-20a__jCzH5-PL2fBP7pqN7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1179514618</pqid></control><display><type>article</type><title>Examining stage IIB survival in a population‐based cohort of patients with colorectal cancer</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Urquhart, Robin ; Bu, Jingyu ; Grunfeld, Eva ; Dewar, Ron ; MacIntyre, Maureen ; Porter, Geoffrey A.</creator><creatorcontrib>Urquhart, Robin ; Bu, Jingyu ; Grunfeld, Eva ; Dewar, Ron ; MacIntyre, Maureen ; Porter, Geoffrey A.</creatorcontrib><description>BACKGROUND:
In Nova Scotia, Canada, a previous study of colorectal cancer (CRC) cases diagnosed between January 1, 2001, and December 31, 2005, found that patients with stage IIB CRC had similar 5‐year overall survival (OS) to those with stage IIIC cancer. This study sought to examine factors contributing to the observed stage IIB outcome, specifically nodal harvest, receipt of chemotherapy, and use of a new coding system to derive stage.
METHODS:
The provincial cancer registry identified all CRC cases diagnosed during the study period and staged this cohort using the Collaborative Stage (CS) Data Collection System. All patients with stage II and III cancer in the cohort were examined. Kaplan‐Meier (KM) survival curves compared 5‐year OS for patients with stage IIB cancer based on the factors of interest, and compared patients with stage IIB cancer to those with stage IIA and III cancer.
RESULTS:
OS for patients with stage IIB cancer (n = 187) was 44.7%, and differed depending on adequacy of nodal harvest (P = .005) and whether pathological or clinical/mixed evidence was used to derive stage (P = .013). Pathologically‐staged patients with stage IIB cancer who had adequate nodal harvest had marginally improved OS compared to pathologically‐staged patients who had inadequate nodal harvest (P = .07), and improved survival compared to patients with clinical/mixed stage (P = .004). Pathologically‐staged patients with stage IIB cancer with adequate nodal harvest demonstrated similar 5‐year OS to those with stage IIA and III cancer (P = .52 and P = .25, respectively). Cox proportional hazards models supported these findings.
CONCLUSIONS:
The inclusion of clinical/mixed evidence into staging classification and, perhaps to a lesser extent, the adequacy of nodal harvest appear to contribute to the observed worse survival for patients with stage IIB versus stage III cancer. Cancer 2012. © 2012 American Cancer Society.
The inclusion of clinical and mixed evidence into the stage classification algorithms used by the Collaborative Stage Data Collection System and the adequacy of nodal harvest appear to have contributed to the poor survival that was observed in a population‐based cohort of patients with stage IIB colorectal cancer. The impact of nodal harvest on survival was less when stage was derived using only pathologic evidence.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.27610</identifier><identifier>PMID: 22648789</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Cohort Studies ; colorectal neoplasms ; Colorectal Neoplasms - mortality ; Colorectal Neoplasms - pathology ; drug therapy ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; lymph nodes ; Male ; Medical sciences ; Middle Aged ; mortality ; Neoplasm Staging ; staging ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Survival Analysis ; Tumors</subject><ispartof>Cancer, 2012-12, Vol.118 (23), p.5973-5981</ispartof><rights>Copyright © 2012 American Cancer Society</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2012 American Cancer Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3870-79096f0786c1d1925fba758685a8a998ce4c409cd53d8b013ff57230bf3008dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.27610$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.27610$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26679607$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22648789$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Urquhart, Robin</creatorcontrib><creatorcontrib>Bu, Jingyu</creatorcontrib><creatorcontrib>Grunfeld, Eva</creatorcontrib><creatorcontrib>Dewar, Ron</creatorcontrib><creatorcontrib>MacIntyre, Maureen</creatorcontrib><creatorcontrib>Porter, Geoffrey A.</creatorcontrib><title>Examining stage IIB survival in a population‐based cohort of patients with colorectal cancer</title><title>Cancer</title><addtitle>Cancer</addtitle><description>BACKGROUND:
In Nova Scotia, Canada, a previous study of colorectal cancer (CRC) cases diagnosed between January 1, 2001, and December 31, 2005, found that patients with stage IIB CRC had similar 5‐year overall survival (OS) to those with stage IIIC cancer. This study sought to examine factors contributing to the observed stage IIB outcome, specifically nodal harvest, receipt of chemotherapy, and use of a new coding system to derive stage.
METHODS:
The provincial cancer registry identified all CRC cases diagnosed during the study period and staged this cohort using the Collaborative Stage (CS) Data Collection System. All patients with stage II and III cancer in the cohort were examined. Kaplan‐Meier (KM) survival curves compared 5‐year OS for patients with stage IIB cancer based on the factors of interest, and compared patients with stage IIB cancer to those with stage IIA and III cancer.
RESULTS:
OS for patients with stage IIB cancer (n = 187) was 44.7%, and differed depending on adequacy of nodal harvest (P = .005) and whether pathological or clinical/mixed evidence was used to derive stage (P = .013). Pathologically‐staged patients with stage IIB cancer who had adequate nodal harvest had marginally improved OS compared to pathologically‐staged patients who had inadequate nodal harvest (P = .07), and improved survival compared to patients with clinical/mixed stage (P = .004). Pathologically‐staged patients with stage IIB cancer with adequate nodal harvest demonstrated similar 5‐year OS to those with stage IIA and III cancer (P = .52 and P = .25, respectively). Cox proportional hazards models supported these findings.
CONCLUSIONS:
The inclusion of clinical/mixed evidence into staging classification and, perhaps to a lesser extent, the adequacy of nodal harvest appear to contribute to the observed worse survival for patients with stage IIB versus stage III cancer. Cancer 2012. © 2012 American Cancer Society.
The inclusion of clinical and mixed evidence into the stage classification algorithms used by the Collaborative Stage Data Collection System and the adequacy of nodal harvest appear to have contributed to the poor survival that was observed in a population‐based cohort of patients with stage IIB colorectal cancer. The impact of nodal harvest on survival was less when stage was derived using only pathologic evidence.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>colorectal neoplasms</subject><subject>Colorectal Neoplasms - mortality</subject><subject>Colorectal Neoplasms - pathology</subject><subject>drug therapy</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>lymph nodes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>mortality</subject><subject>Neoplasm Staging</subject><subject>staging</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Survival Analysis</subject><subject>Tumors</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90MlKBDEQBuAgio7LxQeQXAQRWiu9ZDnq4DIgCqLgySadTjTS02mTbpebj-Az-iRGZ9Sbp5DUlyrqR2iTwB4BSPdVq_xeyiiBBTQiIFgCJE8X0QgAeFLk2c0KWg3hIV5ZWmTLaCVNac4ZFyN0e_Qip7a17R0OvbzTeDI5xGHwT_ZJNti2WOLOdUMje-vaj7f3SgZdY-Xune-xM7iLBd32AT_b_j6-N85r1cevSrZK-3W0ZGQT9Mb8XEPXx0dX49Pk7OJkMj44S1TGGSRMgKAGGKeK1ESkhakkKzjlheRSCK50rnIQqi6ymldAMmMKlmZQmSyuWNfZGtqZ9e28exx06MupDUo3jWy1G0JJCBMFySnhke7OqPIuBK9N2Xk7lf61JFB-5Vl-5Vl-5xnx1rzvUE11_Ut_Aoxgew5kULIxPq5tw5-jlAkKLDoyc8-20a__jCzH5-PL2fBP7pqN7Q</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>Urquhart, Robin</creator><creator>Bu, Jingyu</creator><creator>Grunfeld, Eva</creator><creator>Dewar, Ron</creator><creator>MacIntyre, Maureen</creator><creator>Porter, Geoffrey A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Examining stage IIB survival in a population‐based cohort of patients with colorectal cancer</title><author>Urquhart, Robin ; Bu, Jingyu ; Grunfeld, Eva ; Dewar, Ron ; MacIntyre, Maureen ; Porter, Geoffrey A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3870-79096f0786c1d1925fba758685a8a998ce4c409cd53d8b013ff57230bf3008dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>colorectal neoplasms</topic><topic>Colorectal Neoplasms - mortality</topic><topic>Colorectal Neoplasms - pathology</topic><topic>drug therapy</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>lymph nodes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>mortality</topic><topic>Neoplasm Staging</topic><topic>staging</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Survival Analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Urquhart, Robin</creatorcontrib><creatorcontrib>Bu, Jingyu</creatorcontrib><creatorcontrib>Grunfeld, Eva</creatorcontrib><creatorcontrib>Dewar, Ron</creatorcontrib><creatorcontrib>MacIntyre, Maureen</creatorcontrib><creatorcontrib>Porter, Geoffrey A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Urquhart, Robin</au><au>Bu, Jingyu</au><au>Grunfeld, Eva</au><au>Dewar, Ron</au><au>MacIntyre, Maureen</au><au>Porter, Geoffrey A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Examining stage IIB survival in a population‐based cohort of patients with colorectal cancer</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>118</volume><issue>23</issue><spage>5973</spage><epage>5981</epage><pages>5973-5981</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>BACKGROUND:
In Nova Scotia, Canada, a previous study of colorectal cancer (CRC) cases diagnosed between January 1, 2001, and December 31, 2005, found that patients with stage IIB CRC had similar 5‐year overall survival (OS) to those with stage IIIC cancer. This study sought to examine factors contributing to the observed stage IIB outcome, specifically nodal harvest, receipt of chemotherapy, and use of a new coding system to derive stage.
METHODS:
The provincial cancer registry identified all CRC cases diagnosed during the study period and staged this cohort using the Collaborative Stage (CS) Data Collection System. All patients with stage II and III cancer in the cohort were examined. Kaplan‐Meier (KM) survival curves compared 5‐year OS for patients with stage IIB cancer based on the factors of interest, and compared patients with stage IIB cancer to those with stage IIA and III cancer.
RESULTS:
OS for patients with stage IIB cancer (n = 187) was 44.7%, and differed depending on adequacy of nodal harvest (P = .005) and whether pathological or clinical/mixed evidence was used to derive stage (P = .013). Pathologically‐staged patients with stage IIB cancer who had adequate nodal harvest had marginally improved OS compared to pathologically‐staged patients who had inadequate nodal harvest (P = .07), and improved survival compared to patients with clinical/mixed stage (P = .004). Pathologically‐staged patients with stage IIB cancer with adequate nodal harvest demonstrated similar 5‐year OS to those with stage IIA and III cancer (P = .52 and P = .25, respectively). Cox proportional hazards models supported these findings.
CONCLUSIONS:
The inclusion of clinical/mixed evidence into staging classification and, perhaps to a lesser extent, the adequacy of nodal harvest appear to contribute to the observed worse survival for patients with stage IIB versus stage III cancer. Cancer 2012. © 2012 American Cancer Society.
The inclusion of clinical and mixed evidence into the stage classification algorithms used by the Collaborative Stage Data Collection System and the adequacy of nodal harvest appear to have contributed to the poor survival that was observed in a population‐based cohort of patients with stage IIB colorectal cancer. The impact of nodal harvest on survival was less when stage was derived using only pathologic evidence.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>22648789</pmid><doi>10.1002/cncr.27610</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 2012-12, Vol.118 (23), p.5973-5981 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1179514618 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adult Aged Biological and medical sciences Cohort Studies colorectal neoplasms Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology drug therapy Female Gastroenterology. Liver. Pancreas. Abdomen Humans lymph nodes Male Medical sciences Middle Aged mortality Neoplasm Staging staging Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Survival Analysis Tumors |
| title | Examining stage IIB survival in a population‐based cohort of patients with colorectal cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T20%3A42%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Examining%20stage%20IIB%20survival%20in%20a%20population%E2%80%90based%20cohort%20of%20patients%20with%20colorectal%20cancer&rft.jtitle=Cancer&rft.au=Urquhart,%20Robin&rft.date=2012-12-01&rft.volume=118&rft.issue=23&rft.spage=5973&rft.epage=5981&rft.pages=5973-5981&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/cncr.27610&rft_dat=%3Cproquest_cross%3E1179514618%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1179514618&rft_id=info:pmid/22648789&rfr_iscdi=true |